Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 193
2021 658
2022 841
2023 622
2024 375
2025 287
2026 120

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2,805 results

Results by year

Filters applied: . Clear all
Page 1
COVID-19 vaccine development: milestones, lessons and prospects.
Li M, Wang H, Tian L, Pang Z, Yang Q, Huang T, Fan J, Song L, Tong Y, Fan H. Li M, et al. Signal Transduct Target Ther. 2022 May 3;7(1):146. doi: 10.1038/s41392-022-00996-y. Signal Transduct Target Ther. 2022. PMID: 35504917 Free PMC article. Review.
Existing SARS-CoV-2 vaccines mainly include inactivated, live attenuated, viral vector, protein subunit, RNA, DNA, and virus-like particle (VLP) vaccines. ...Here, we systemically assess the safety and efficacy of COVID-19 vacci …
Existing SARS-CoV-2 vaccines mainly include inactivated, live attenuated, viral vector, protein subunit, RNA, DN …
COVID-19 vaccine development from the perspective of cancer patients.
He Y, Ding Y, Cao B, Huang Y, Wang X. He Y, et al. Hum Vaccin Immunother. 2021 Oct 3;17(10):3281-3287. doi: 10.1080/21645515.2021.1943988. Epub 2021 Jun 25. Hum Vaccin Immunother. 2021. PMID: 34170788 Free PMC article. Review.
This mini-review aims to discuss the impact of COVID-19 on cancer patients, and the urgent need of COVID-19 vaccines for cancer patients. ...In addition, we included an original survey of the acceptance of the COVI …
This mini-review aims to discuss the impact of COVID-19 on cancer patients, and the urgent need of COVID- …
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials.
Desai A, Gainor JF, Hegde A, Schram AM, Curigliano G, Pal S, Liu SV, Halmos B, Groisberg R, Grande E, Dragovich T, Matrana M, Agarwal N, Chawla S, Kato S, Morgan G, Kasi PM, Solomon B, Loong HH, Park H, Choueiri TK, Subbiah IM, Pemmaraju N, Subbiah V; COVID19 and Cancer Clinical Trials Working Group. Desai A, et al. Nat Rev Clin Oncol. 2021 May;18(5):313-319. doi: 10.1038/s41571-021-00487-z. Epub 2021 Mar 15. Nat Rev Clin Oncol. 2021. PMID: 33723371 Free PMC article. Review.
Emerging efficacy data have led to the emergency use authorization or approval of COVID-19 vaccines in several countries worldwide. Most trials of COVID-19 vaccines excluded patients with active malignancies, and thus data on the s …
Emerging efficacy data have led to the emergency use authorization or approval of COVID-19 vaccines in several countrie …
Evaluation of COVID-19 vaccine response in patients with cancer: An interim analysis.
Tran S, Truong TH, Narendran A. Tran S, et al. Eur J Cancer. 2021 Dec;159:259-274. doi: 10.1016/j.ejca.2021.10.013. Epub 2021 Oct 25. Eur J Cancer. 2021. PMID: 34798454 Free PMC article. Review.
RESULTS: In general, a single dose of the COVID-19 vaccine yields weaker and heterogeneous serological responses in both patients with haematological and solid malignancies. ...COVID-19 vaccines are safe and well-tolerated in pa …
RESULTS: In general, a single dose of the COVID-19 vaccine yields weaker and heterogeneous serological responses in bot …
COVID-19 vaccine response and safety in patients with cancer: An overview of systematic reviews.
Sun H, Bu F, Li L, Zhang X, Yan J, Huang T. Sun H, et al. Front Public Health. 2022 Nov 15;10:1072137. doi: 10.3389/fpubh.2022.1072137. eCollection 2022. Front Public Health. 2022. PMID: 36457318 Free PMC article.
There are still some doubts about efficacy and safety of the COVID-19 vaccine in cancer patients. PURPOSE: To identify, summarize and synthesize the available evidence of systematic reviews on response and COVID-19 vaccine s …
There are still some doubts about efficacy and safety of the COVID-19 vaccine in cancer patients. PURPOSE …
COVID vaccination and post-infection cancer signals: Evaluating patterns and potential biological mechanisms.
Kuperwasser C, El-Deiry WS. Kuperwasser C, et al. Oncotarget. 2026 Jan 3;17:1-29. doi: 10.18632/oncotarget.28824. Oncotarget. 2026. PMID: 41498242 Free PMC article. Review.
A growing number of peer-reviewed publications have reported diverse cancer types appearing in temporal association with COVID-19 vaccination or infection. ...These findings underscore the need for rigorous epidemiologic, longitudinal, clinical, histopatholog …
A growing number of peer-reviewed publications have reported diverse cancer types appearing in temporal association with COVID …
Cancer vaccines and the future of immunotherapy.
Pail O, Lin MJ, Anagnostou T, Brown BD, Brody JD. Pail O, et al. Lancet. 2025 Jul 12;406(10499):189-202. doi: 10.1016/S0140-6736(25)00553-7. Epub 2025 Jun 18. Lancet. 2025. PMID: 40541217 Review.
Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 pandemic. ...In this Viewpoint, we analyse cancer vaccine trials, the strengths and limitations of different vaccine ap …
Vaccines have had a major impact on the control of infectious disease, most recently by helping to combat the COVID-19 …
COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature.
Lim J, Lee SA, Khil EK, Byeon SJ, Kang HJ, Choi JA. Lim J, et al. Semin Oncol. 2021 Aug-Dec;48(4-6):283-291. doi: 10.1053/j.seminoncol.2021.10.002. Epub 2021 Oct 26. Semin Oncol. 2021. PMID: 34836672 Free PMC article. Review.
PURPOSE: Lymphadenopathy (LAP) after COVID-19 vaccination in patients with a diagnosis of cancer has been challenging. We analyzed imaging and clinical features from early cases of axillary LAP in six COVID-19 vaccine recipients wi …
PURPOSE: Lymphadenopathy (LAP) after COVID-19 vaccination in patients with a diagnosis of cancer has been challe …
Vaccination of Adults With Cancer: ASCO Guideline.
Kamboj M, Bohlke K, Baptiste DM, Dunleavy K, Fueger A, Jones L, Kelkar AH, Law LY, LeFebvre KB, Ljungman P, Miller ED, Meyer LA, Moore HN, Soares HP, Taplitz RA, Woldetsadik ES, Kohn EC. Kamboj M, et al. J Clin Oncol. 2024 May 10;42(14):1699-1721. doi: 10.1200/JCO.24.00032. Epub 2024 Mar 18. J Clin Oncol. 2024. PMID: 38498792 Free PMC article.
RESULTS: A total of 102 publications were included in the systematic review: 24 systematic reviews, 14 RCTs, and 64 nonrandomized studies. The largest body of evidence addressed COVID-19 vaccines. RECOMMENDATIONS: The goal of vaccination is to limit the sever …
RESULTS: A total of 102 publications were included in the systematic review: 24 systematic reviews, 14 RCTs, and 64 nonrandomized studies. T …
2,805 results